A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Vygon Acquires Macatt Medica

Peruvian distributor of single-use medical devices. Takeover will enable Vygon to build on its presence in South America, particularly in enteral nutrition sector.

Vygon, a specialist single-use medical devices group, today announces the acquisition of Macatt Medica, a distribution company located in Lima, Peru.

The company distributes the majority of Vygon’s products in Peru, including a wide range of enteral nutrition products. The financial terms of the agreement have not been disclosed.

With this acquisition, Macatt Medica will become a fully owned subsidiary; boosting Vygon’s presence in South America. Its 21 employees will be joining Vygon’s staff.

“We are delighted that Macatt is joining the extended Vygon family and, in particular, that this will enable us to strengthen our presence on the market for active medical devices,” said Michel Hanania, vice president for the Latin America region at Vygon.

Hanania added, “This product range will complement the one that we have developed alongside our branch in Colombia, in the area of single-use ‘consumable’ products, which will enable us to offer a comprehensive range of products to our South American client base.”

“It’s a big step forward for Macatt to become Vygon’s Peru subsidiary; we are already working closely, distributing its products; this takeover is a natural progression for our company,” said Manuel Catalan, CEO of Macatt Medica. “This acquisition is an opportunity for Macatt to boost its presence on the distribution market for enteral nutrition products, while at the same time becoming part of a group which shares the same values as us.”

Founded in 1997, Macatt Medica has been distributing Vygon products since 2010. Its turnover rose to €1.7 million ($1.9M) in 2021.

SourceVygon
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy